156 related articles for article (PubMed ID: 11309300)
21. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
22. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
Koch A; Denkhaus D; Albrecht S; Leuschner I; von Schweinitz D; Pietsch T
Cancer Res; 1999 Jan; 59(2):269-73. PubMed ID: 9927029
[TBL] [Abstract][Full Text] [Related]
23. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
Zurawel RH; Chiappa SA; Allen C; Raffel C
Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
[TBL] [Abstract][Full Text] [Related]
24. Beta-catenin mutations in sporadic fundic gland polyps.
Sekine S; Shibata T; Yamauchi Y; Nakanishi Y; Shimoda T; Sakamoto M; Hirohashi S
Virchows Arch; 2002 Apr; 440(4):381-6. PubMed ID: 11956818
[TBL] [Abstract][Full Text] [Related]
25. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
26. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
[TBL] [Abstract][Full Text] [Related]
27. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
[TBL] [Abstract][Full Text] [Related]
28. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
29. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors.
Kitaeva MN; Grogan L; Williams JP; Dimond E; Nakahara K; Hausner P; DeNobile JW; Soballe PW; Kirsch IR
Cancer Res; 1997 Oct; 57(20):4478-81. PubMed ID: 9377556
[TBL] [Abstract][Full Text] [Related]
30. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
32. Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability.
Kim IJ; Kang HC; Park JH; Shin Y; Ku JL; Lim SB; Park SY; Jung SY; Kim HK; Park JG
Clin Cancer Res; 2003 Aug; 9(8):2920-5. PubMed ID: 12912937
[TBL] [Abstract][Full Text] [Related]
33. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
34. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
35. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
[TBL] [Abstract][Full Text] [Related]
37. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
38. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
Schlosshauer PW; Pirog EC; Levine RL; Ellenson LH
Mod Pathol; 2000 Oct; 13(10):1066-71. PubMed ID: 11048799
[TBL] [Abstract][Full Text] [Related]
40. Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype.
Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Ohta T; Shibata K; Oda K; Wada H; Tominaga S; Matsuda Y; Ohsawa M; Nakamura Y; Shimano T
Am J Gastroenterol; 2000 Jun; 95(6):1576-80. PubMed ID: 10894600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
